Login / Signup

Immune Effective Score as a Predictor of Response to Neoadjuvant Trastuzumab Therapy and a Prognostic Indicator for HER2-Positive Breast Cancer.

Xueying WuChenyang ZhangHenghui Zhang
Published in: Current oncology (Toronto, Ont.) (2022)
IES has a predictive value for response to neoadjuvant trastuzumab therapy and independent prognostic value for HER2-positive breast cancer.
Keyphrases
  • positive breast cancer
  • rectal cancer
  • lymph node
  • locally advanced
  • epidermal growth factor receptor
  • metastatic breast cancer
  • squamous cell carcinoma
  • stem cells
  • radiation therapy
  • mesenchymal stem cells
  • bone marrow